53.4 F
New York
Wednesday, November 25, 2020

Aurora Cannabis Inc (OTCMKTS:ACBFF) Goes Back to its Roots

Must read

Renewed Optimism is Surrounding Magellan Midstream Partners L.P. (NYSE:MMP)

Magellan Midstream Partners L.P. (MMP) shares are trading at higher $44.07 and the avg recommendation for the stock is Moderate Buy, while the current...

When Will KAR Auction Services Inc. (KAR) Slow Down

KAR Auction Services Inc. (KAR) shares are trading at higher $18.44 and the avg recommendation for the stock is Moderate Buy, while the current...

Will ORBCOMM Inc. (ORBC) Find a Support Level Soon?

ORBCOMM Inc. (ORBC) shares are trading at lower $6.17 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

Grayscale Bitcoin Trust (OTCMKTS:GBTC) Hits New Highs As Bitcoin Crosses $19K

The rally in Bitcoin over the past few weeks has been quite remarkable and hence, it is not...

With its frequent acquisitions and strategic investments, Aurora Cannabis Inc (OTCMKTS:ACBFF) always provides a new spin on the Canadian cannabis narrative through constant diversification. However, the company also clearly knows where its core value proposition sits because it also continues to invest in building its brand as the premier high-potency MMJ player in the game.

As a case in point, the company just announced the launch of new product line called Aurora Frost. According to the company’s release, “this new dried cannabis product line represents the highest potency offering of any Aurora product launched to date at over 35% THC. Aurora Frost products are produced from premium whole flower. The products, generally known throughout the industry as kief, consist primarily of trichomes, the resinous glands rich in active pharmaceutical ingredients, including terpenes, flavonoids, and cannabinoids, such as THC and CBD.”

Aurora Cannabis Inc (OTCMKTS:ACBFF) is a licensed producer of medical marijuana pursuant to the Marijuana for Medical Purposes Regulations and operates a 55,200 square foot expandable state-of-the-art production facility in Alberta, Canada.

ACBFF’s wholly-owned subsidiary, Australis Capital Inc., seeks to be an active participant in the U.S. Cannabis market. Aurora is trading on the Canadian Securities Exchange under the trading symbol “ACB”. The company is headquartered in Vancouver, Canada.

According to company’s materials, “Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations. The Company operates a 55,200 square foot, state-of-the-art facility in Mountain View County, Alberta, is currently constructing a second 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport, and has acquired, and is undertaking completion of a third a 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal’s West Island. In addition, the Company holds approximately 9.6% of the issued shares (12.9% on a fully-diluted basis) in leading extraction technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber for an ownership stake of up to 50.1%. Furthermore, Aurora is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union, based in Germany.”

Find out when $ACBFF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Traders will note roughly flat action tacked on to share pricing for the company in the past month. Furthermore, the stock has seen a growing influx of trading interest, with the stock’s recent average trading volume running 18% over what the stock has registered over the longer term.

“Successfully developing a proprietary, fine trimming and GMP compliant technology needed to produce these high-quality products at commercial scale, provides us with a remarkable advantage in addressing this niche of the cannabis market,” said Terry Booth, CEO. “Aurora now makes this high potency medical cannabis available to its patients, reflecting the Aurora Standard of innovation and patient care.”

Earning a current market cap value of $3.5B, ACBFF has a significant war chest ($231M) of cash on the books, which is balanced by about $2.6M in total current liabilities. One should also note that debt has been growing over recent quarters. ACBFF is pulling in trailing 12-month revenues of $42M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 211.1%. You can bet we will update this one again as new information comes into view. Sign-up for continuing coverage on shares of $ACBFF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $ACBFF, either long or short, and we have not been compensated for this article.

Latest article

MasTec Inc. (NYSE:MTZ) is Gaining Momentum on Earnings Catalyst

MasTec Inc. (MTZ) shares are trading at higher $59.23 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

Is the Rough Ride Over for Signet Jewelers Limited (SIG)

Signet Jewelers Limited (SIG) shares are trading at higher $31.20 and the avg recommendation for the stock is Hold, while the current analyst price...

PDL BioPharma Inc. (NASDAQ:PDLI) Recent Earnings Shows Major Promise

PDL BioPharma Inc. (PDLI) shares are trading at higher $2.50, while the current analyst price target stands at $2.50. To add more color to...

Will Pentair plc (PNR) Find a Support Level Soon?

Pentair plc (PNR) shares are trading at higher $54.09 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Inuvo Inc. (AMEX:INUV) Finding Zero Support

Inuvo Inc. (INUV) shares are trading at lower $0.36 and the avg recommendation for the stock is Moderate Buy. To add more color to...